Based on the forecasted data for analgesic medicine sales in Spain, the value per capita is projected to rise consistently from 2024 to 2028. The values expressed indicate a steady increase each year, starting from 20.1 USD per capita in 2024 and reaching 20.9 USD per capita by 2028. It is worth noting that there has been no decline or significant fluctuation, showcasing a stable growth pattern.
To provide a historical context, the equivalent value in 2023 stood at 19.9 USD per capita.
Year-on-year variation percentages reveal a roughly even growth of about 1% per year. The average annual variation (CAGR) over the last five years confirms a similar trend, around 1% growth per annum.
Future trends to watch for:
- Innovations in pain management and new analgesic formulations entering the market.
- Changes in healthcare policies and guidelines impacting prescription practices.
- Increased consumer awareness and preference for over-the-counter pain relief options.
- Economic factors and disposable income levels which could influence per capita spending on healthcare products.
